We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
–
AUM
$209M
AUM Growth
+$2.68M
Cap. Flow
+$1.78M
Cap. Flow %
0.85%
Top 10 Hldgs %
54.48%
Holding
72
New
5
Increased
39
Reduced
22
Closed
4

Top Buys

1
NULV icon
Nuveen ESG Large-Cap Value ETF
NULV
+$10.9M
2
NVDA icon
NVIDIA
NVDA
+$1.39M
3
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$1.22M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.21M
5
JPM icon
JPMorgan Chase
JPM
+$639K

Top Sells

1
ESGD icon
iShares ESG Aware MSCI EAFE ETF
ESGD
+$16.6M
2
ESGG icon
FlexShares STOXX Global ESG Select Index Fund
ESGG
+$796K
3
VTV icon
Vanguard Value ETF
VTV
+$262K
4
PDP icon
Invesco Dorsey Wright Momentum ETF
PDP
+$262K
5
MDT icon
Medtronic
MDT
+$257K

Sector Composition

1 Technology 1.84%
2 Healthcare 1.53%
3 Financials 0.63%
4 Industrials 0.4%
5 Consumer Staples 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAGG icon
51
iShares Core International Aggregate Bond Fund
IAGG
$10.6B
$361K 0.17%
+7,232
New +$360K
REGN icon
52
Regeneron Pharmaceuticals
REGN
$70.9B
$345K 0.17%
328
-16
-5% -$15.5K
RPAR icon
53
RPAR Risk Parity ETF
RPAR
$574M
$313K 0.15%
16,399
-2,667
-14% -$51K
REET icon
54
iShares Global REIT ETF
REET
$5.05B
$305K 0.15%
13,137
-2,117
-14% -$48.4K
PM icon
55
Philip Morris
PM
$301B
$278K 0.13%
+2,738
New +$268K
TMO icon
56
Thermo Fisher Scientific
TMO
$198B
$253K 0.12%
456
-50
-10% -$28.6K
KRON
57
DELISTED
Kronos Bio
KRON
$167K 0.08%
134,998
+57,867
+75% +$58.9K
ZURA icon
58
Zura Bio
ZURA
$518M
$145K 0.07%
41,569
+7,531
+22% +$30.7K
IMTX icon
59
Immatics
IMTX
$1.31B
$139K 0.07%
+11,987
New +$135K
COGT icon
60
Cogent Biosciences
COGT
$6.68B
$132K 0.06%
15,627
-3,648
-19% -$27.7K
MREO
61
Mereo BioPharma
MREO
$49.5M
$130K 0.06%
36,231
-7,586
-17% -$24.6K
LONA
62
LeonaBio Inc
LONA
$67.8M
$123K 0.06%
4,660
+2,598
+126% +$61.3K
TVTX icon
63
Travere Therapeutics
TVTX
$5.27B
$109K 0.05%
13,317
+1,237
+10% +$8.33K
PSTX
64
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$87.1K 0.04%
29,817
+3,037
+11% +$8.31K
GERN icon
65
Geron
GERN
$924M
$84.4K 0.04%
19,906
+2,030
+11% +$7.91K
ANNX icon
66
Annexon
ANNX
$950M
$78.9K 0.04%
16,103
+1,285
+9% +$6.65K
CTMX icon
67
CytomX Therapeutics
CTMX
$788M
$78.2K 0.04%
64,065
+43,176
+207% +$85.9K
NKTX icon
68
Nkarta
NKTX
$186M
$69.9K 0.03%
+11,833
New +$83.7K
ALXO icon
69
ALX Oncology
ALXO
$283M
– –
-10,261
Closed -$114K
ESGD icon
70
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
– –
-207,750
Closed -$16.6M
MDT icon
71
Medtronic
MDT
$106B
– –
-2,952
Closed -$257K
ACHL
72
DELISTED
Achilles Therapeutics
ACHL
– –
-95,445
Closed -$119K
1 2
3

Similar funds

NC
nVerses Capital Wellington, Florida $110M AUM
PXPO
Peak XV Partners Operations Trianon, Mauritius $110M AUM 43.09% 1-Year Est. Return
OWA
OakTrust Wealth Advisors Wilton, Connecticut $110M AUM
MCM
Masterton Capital Management New York $110M AUM 3.55% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return
NA
NWM Advisors San Luis Obispo, California $110M AUM
NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
BCM
Bond Capital Management San Francisco, California $110M AUM 16.91% 1-Year Est. Return

Forefront Analytics's Q2 2024 Portfolio in Review

As of Q2 2024, Forefront Analytics held 72 positions worth $209M, up 1.3% from $206M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Forefront Analytics's Q2 2024 filing shows 5 new, 39 increased, 22 reduced and 4 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 4,975 shares worth $384K. The largest sale was iShares ESG Aware MSCI EAFE ETF, an estimated $16.6M.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 0.76% a quarter earlier, followed by Healthcare and Financials.

  • Forefront Analytics's largest Q2 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 4,975 shares worth $384K.
  • Forefront Analytics added most to Nuveen ESG Large-Cap Value ETF in Q2 2024, an estimated $10.9M increase.
  • Forefront Analytics's biggest Q2 2024 reduction was FlexShares STOXX Global ESG Select Index Fund, cutting an estimated $796K.
  • Forefront Analytics fully exited iShares ESG Aware MSCI EAFE ETF in Q2 2024, selling an estimated $16.6M.
  • Forefront Analytics's ten largest holdings make up 54% of its $209M portfolio in Q2 2024.
  • Forefront Analytics opened 5 new positions and closed 4 in Q2 2024.
  • Forefront Analytics's portfolio value rose 1.3% quarter-over-quarter to $209M.

Based on Forefront Analytics's 13F filing for Q2 2024, filed 15 Aug 2024.